Feb 6 |
Insider Sell: President Cam Gallagher Sells 11,552 Shares of Zentalis Pharmaceuticals Inc (ZNTL)
|
Feb 5 |
Zentalis: Leading WEE1 Developer After AstraZeneca's Exit
|
Jan 25 |
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
|
Jan 8 |
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
|
Dec 27 |
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Is In A Good Position To Deliver On Growth Plans
|
Nov 16 |
David Johnson Bought 16% More Shares In Zentalis Pharmaceuticals
|
Nov 14 |
Zentalis Pharmaceuticals director purchases 17K company shares
|
Nov 14 |
Zentalis: Latest Market Sell-Off Looks Justified With Data Catalysts Long Way Off
|
Nov 14 |
Director David Johnson's Strategic Purchase of Zentalis Pharmaceuticals Inc Shares
|